Showing results (421-430 of 781) with videos related to

Sort By:
Pageof 79
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasiasConstantine S Mitsiades, Cecile Rouleau, Cinara Echart, et al.
JCI Insight|February 8, 2023
Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myelomaJana Jakubikova, Danka Cholujova, Gabor Beke, et al.
Blood|January 17, 2013
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humansGüllü Topal Görgün, Gregory Whitehill, Jennifer L Anderson, et al.
Haematologica|July 5, 2006
Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib aloneSundar Jagannath, Paul G Richardson, Bart Barlogie, et al.
Oncotarget|November 17, 2016
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myelomaLihui Shi, Xiaoqi Qin, Huijun Wang, et al.
Annals of Hematology|September 19, 2014
Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patientsGang An, Xiaoqi Qin, Chirag Acharya, et al.
Proteomics|March 3, 2011
A novel panel of protein biomarkers for predicting response to thalidomide-based therapy in newly diagnosed multiple myeloma patientsRajesh Rajpal, Paul Dowling, Justine Meiller, et al.
Blood|June 26, 2004
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosisSteven Le Gouill, Klaus Podar, Martine Amiot, et al.
Blood|May 14, 2009
Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cellsTeru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, et al.
Blood|March 16, 2010
A proto-oncogene BCL6 is up-regulated in the bone marrow microenvironment in multiple myeloma cellsTeru Hideshima, Constantine Mitsiades, Hiroshi Ikeda, et al.
Pageof 79